ALICIA MOORE: Open Payments
NPI 1609570431 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 82 payments from 30 companies in 2025. Trend: 2023 $569 · 2024 $1,482 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $181 |
| Incyte Corporation | 8 | $143 |
| Daiichi Sankyo Inc. | 7 | $138 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Novartis Pharmaceuticals Corporation | 6 | $104 |
| ABBVIE INC. | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Eisai Inc. | 3 | $52 |
| Celgene Corporation | 3 | $50 |
| PFIZER INC. | 3 | $49 |
Products named: KEYTRUDA, JAKAFI, KISQALI, Enhertu, Nubeqa, MONJUVI, Lenvima, DATROWAY.
Industry payments across AR — which companies pay providers there.
